MON-LB054 Activity of Prolactin Receptor Antagonist-Rapamycin Conjugate in Glioblastoma Multiform
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the Endocrine Society"
DOI: 10.1210/js.2019-mon-lb054
Abstract: Abstract Background: Glioblastoma multiform (GBM) is the most common and aggressive primary brain tumor in humans, accounting for approximately 12-15% of all intracranial tumors, with a median survival of 15 months. Although GBM is not… read more here.
Keywords: rapamycin; antagonist rapamycin; glioblastoma multiform; activity ... See more keywords